Trade Summary

4 days ago, Winters Chad, serving as VP, Chief Accounting Officer at West Pharmaceutical Services Inc (WST), sold 896 shares at $300.67 per share, for a total transaction value of $269,399.00. Following this transaction, Winters Chad now holds 1,523 shares of WST.

This sale represents a 37.00% decrease in Winters Chad's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 27, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 29, 2026, 2 days after the trade was made.